The first confirmed human case of rabies, Timor-Leste, 2024
In March 2024, the first ever human case of rabies, following a dog bite, was detected in Timor-Leste. This paper briefly discusses the circumstances of transmission, clinical presentation, palliative care of the case and public health measures taken. Timor-Leste was previously considered rabies-free. Any person who is bitten or scratched by an animal that could potentially transmit rabies virus (especially dogs, bats, monkeys or cats) in Timor-Leste should be assessed for consideration of provision of rabies post-exposure prophylaxis. (Source: Eurosurveillance)
Source: Eurosurveillance - May 2, 2024 Category: Infectious Diseases Authors: Marcelo Amaral Mali, Filipe de Neri Machado, Filomeno Pinto Moniz, Frederico Bosco Alves dos Santos, Perpetua Ana Mery Estela Laot, Ari Jayanti Pereira Tilman, Tanizio Ebryes Florindo, Cristovao de Alexandria Barros, Adriano Barbosa, Jose A Oliveira Lima, Source Type: research
Raw meat-based diet for pets: a neglected source of human exposure to Salmonella and pathogenic Escherichia coli clones carrying mcr, Portugal, September 2019 to January 2020
ConclusionSome RMBDs from European brands available in Portugal can be a vehicle for clinically relevant MDRSalmonella and pathogenicE. coli clones carrying genes encoding resistance to the last-line antibiotic colistin. Proactive actions within the One Health context, spanning regulatory, pet-food industry and consumer levels, are needed to mitigate these public health risks. (Source: Eurosurveillance)
Source: Eurosurveillance - May 2, 2024 Category: Infectious Diseases Authors: Marisa Ribeiro-Almeida, Joana Mour ão, Mafalda Magalhães, Ana R Freitas, Carla Novais, Luísa Peixe and Patrícia Antunes Source Type: research
A combined cross-sectional analysis and case-control study evaluating tick-borne encephalitis vaccination coverage, disease and vaccine effectiveness in children and adolescents, Switzerland, 2005 to 2022
ConclusionsEven children younger than 5 years can experience severe TBE. Incomplete and complete vaccination protect against neurological manifestations of the disease. Complete vaccination offers durable protection up to 10 years against TBE. (Source: Eurosurveillance)
Source: Eurosurveillance - May 2, 2024 Category: Infectious Diseases Authors: Kyra D Zens, Ekkehardt Altpeter, Monica N Wymann, Annora Mack, Nora B Baer, Sarah R Haile, Robert Steffen, Jan S Fehr and Phung Lang Source Type: research
Authors ’ correction for Euro Surveill. 2024;29(16)
(Source: Eurosurveillance)
Source: Eurosurveillance - April 25, 2024 Category: Infectious Diseases Authors: Eurosurveillance editorial team Source Type: research
Contact tracing management of a measles case in a paediatric hospital: experience of the local public health unit, Portugal, January 2024
In January 2024, a child was diagnosed with measles in a paediatric hospital in Lisbon. Of 123 contacts, 39 (32%) were not fully immunised, presenting a risk for a potential outbreak. The public health unit initiated control measures and identified challenges during the response, such as the lack of interoperability between information systems and accessing vaccination records. The lessons learned prompted changes to national contact tracing procedures for measles, further strengthening Portugal’s preparedness. (Source: Eurosurveillance)
Source: Eurosurveillance - April 25, 2024 Category: Infectious Diseases Authors: Daniel Saldanha Resendes, Ant ónio Tomás, Mariana Pinção Cardoso, Sebastian von Schreeb, Rita Miranda Ferrão, Paula Vasconcelos, Maria Helena Almeida, Bruno Novo Castro, Vasco Ricoca Peixoto, Renato Lourenço Silva and Margarida de Morais Source Type: research
Availability of drugs for the treatment of multidrug-resistant/rifampicin-resistant tuberculosis in the World Health Organization European Region, October 2023
The BPaLM regimen (bedaquiline, pretomanid, linezolid and moxifloxacin) recently recommended by the World Health Organization offers short, safe, and effective treatment for multidrug-resistant/rifampicin-resistant tuberculosis (TB). In a survey with national TB focal points in 18 central and western European countries to explore barriers for the implementation of BPaLM, only three reported full availability of pretomanid, a necessary component of this regimen. Implementation barriers included financing and procurement. Solutions on national and supranational level are needed to guarantee universal access. (Source: Eurosurveillance)
Source: Eurosurveillance - April 25, 2024 Category: Infectious Diseases Authors: Ralf Otto-Knapp, Suzanne Edwards, Giorgi Kuchukhidze, Stefan Kr öger, Brit Häcker, Stela Bivol and Askar Yedilbayev Source Type: research
Severe A(H1N1)pdm09 influenza acute encephalopathy outbreak in children in Tuscany, Italy, December 2023 to January 2024
This report raises awareness for clinicians to identify and treat early acute encephalopathy caused by H1N1 influenza and serves as a reminder of severe presentations of influenza in young children and the importance of vaccination. (Source: Eurosurveillance)
Source: Eurosurveillance - April 25, 2024 Category: Infectious Diseases Authors: Luca Bartolini, Silvia Ricci, Chiara Azzari, Maria Moriondo, Francesco Nieddu, Manuela L ’Erario, Zaccaria Ricci, Gabriele Simonini, Marzia Mortilla, Giuseppe Indolfi, Carlotta Montagnani, Elena Chiappini, Luisa Galli and Renzo Guerrini Source Type: research
Outbreak of invasive Group A streptococcus disease in a nursing home in Ireland in February 2023 caused by emm type 18
We describe the management of an iGAS outbreak involving three nursing home residents in Ireland in early 2023. A regional Department of Public Health was notified of an iGAS case in a nursing home resident in January 2023. When two further cases among residents were notified 7 days later, an outbreak was declared. Surveillance for GAS/iGAS infection in residents and staff was undertaken. The site was visited to provide infection prevention and control (IPC) support. Isolates wereemm typed. A total of 38 residents and 29 staff in contact with resident cases were provided with antibiotic chemoprophylaxis. Seven additi...
Source: Eurosurveillance - April 25, 2024 Category: Infectious Diseases Authors: Ciara Carroll, Mary Meehan, Roisin Connolly, Jayne Prendergast, Colette Magnone, Aine Meehan, Chantal Migone, Keith Ian Quintyne, Caroline Carpenter, Helen Byrne, Robert Cunney and Paul Mullane Source Type: research
Scenarios of future mpox outbreaks among men who have sex with men: a modelling study based on cross-sectional seroprevalence data from the Netherlands, 2022
ConclusionOur findings indicate a reduced likelihood of large future mpox outbreaks among MSM in the Netherlands under current conditions, but emphasise the importance of maintaining population immunity, diagnostic capacities and disease awareness. (Source: Eurosurveillance)
Source: Eurosurveillance - April 25, 2024 Category: Infectious Diseases Authors: Marc C Shamier, Luca M Zaeck, Hannelore M G ötz, Bruno Vieyra, Babs E Verstrepen, Koen Wijnans, Matthijs RA Welkers, Elske Hoornenborg, Brigitte AGL van Cleef, Martin E van Royen, Kai J Jonas, Marion PG Koopmans, Rory D de Vries, David AMC van de Vijver Source Type: research
Rapid molecular epidemiology investigations into two recent measles outbreaks in Israel detected from October 2023 to January 2024
In this study, we validate transmission pathways uncovered by epidemiological investigations using a rapid molecular approach, based on complete measles virus genomes. The presented findings support this rapid molecular approach in complementing conventional contact tracing and highlight its potential for informing public health interventions. (Source: Eurosurveillance)
Source: Eurosurveillance - April 18, 2024 Category: Infectious Diseases Authors: Efrat Bucris, Victoria Indenbaum, Tal Levin, Yara Kanaaneh, Keren Friedman, Tatyana Kushnir, Revka Shefer, Michal Savion, Matanelle Salama, Noa Di-castro, Kozita Labay, Maya Butera, Baraah Shihada, Zohar Mor, Yaniv Lustig and Neta S. Zuckerman Source Type: research
Increased reports of measles in the Metropolitan City of Milan, northern Italy, September 2023 to March 2024
Since late 2023, the Metropolitan City of Milan and surrounding areas (northern Italy) have been experiencing a resurgence of measles, with most cases detected starting from January 2024. During this brief period, we observed measles in travellers from endemic areas, participants in international events, vaccinees and healthcare workers. Indigenous cases have also been identified. Even though we have not yet identified large and disruptive outbreaks, strengthening surveillance and vaccination activities is pivotal to help limit the impact of measles spread. (Source: Eurosurveillance)
Source: Eurosurveillance - April 18, 2024 Category: Infectious Diseases Authors: Maria Gori, Clara Fappani, Silvia Bianchi, Sabrina Senatore, Daniela Colzani, Priscilla Pasutto, Melissa Baggieri, Silvia Gioacchini, Antonella Marchi, Paola Bucci, Emilio D ’Ugo, Marino Faccini, Danilo Cereda, Luigi Vezzosi, Elisabetta Tanzi, Fabio Mag Source Type: research
Emergence of OXA-48-producing Klebsiella pneumoniae in Lithuania, 2023: a multi-cluster, multi-hospital outbreak
In 2023, an increase of OXA-48-producingKlebsiella pneumoniae was noticed by the Lithuanian National Public Health Surveillance Laboratory. Whole genome sequencing (WGS) of 106 OXA-48-producingK. pneumoniae isolates revealed three distinct clusters of carbapenemase-producingK. pneumoniae high-risk clones, including sequence type (ST) 45 (n = 35 isolates), ST392 (n = 32) and ST395 (n = 28), involving six, six and nine hospitals in different regions, respectively. These results enabled targeted investigation and control, and underscore the value of national WGS-based surveillance for antim...
Source: Eurosurveillance - April 18, 2024 Category: Infectious Diseases Authors: Paulius Grei čius, Marius Linkevicius, Jelena Razmuk, Jekaterina Sinotova, Erik Alm, Olov Svartström, Valeria Bortolaia, Eglė Kudirkienė, Louise Roer, Rene S Hendriksen, Gabija Tamoliūnaitė, Daniel Palm, Dominique L Monnet, Anke Kohlenberg and Algir Source Type: research
Multiple introductions of monkeypox virus to Ireland during the international mpox outbreak, May 2022 to October 2023
ConclusionWe provide insights into the international transmission dynamics supporting multiple introductions of MPXV into Ireland. Such information supported the implementation of evidence-informed public health control measures. (Source: Eurosurveillance)
Source: Eurosurveillance - April 18, 2024 Category: Infectious Diseases Authors: Gabriel Gonzalez, Michael Carr, Tom ás M Kelleher, Emer O’Byrne, Weronika Banka, Brian Keogan, Charlene Bennett, Geraldine Franzoni, Patrice Keane, Cliona Kenna, Luke W Meredith, Nicola Fletcher, Jose Maria Urtasun-Elizari, Jonathan Dean, Ciaran Browne Source Type: research
Excess mortality in Europe coincides with peaks of COVID-19, influenza and respiratory syncytial virus (RSV), November 2023 to February 2024
Since the end of November 2023, the European Mortality Monitoring Network (EuroMOMO) has observed excess mortality in Europe. During weeks 48 2023–6 2024, preliminary results show a substantially increased rate of 95.3 (95% CI: 91.7–98.9) excess all-cause deaths per 100,000 person-years for all ages. This excess mortality is seen in adults aged 45 years and older, and coincides with widespread presence of COVID-19, influenza and respiratory syncytial virus (RSV) observed in many European countries during the 2023/24 winter season. (Source: Eurosurveillance)
Source: Eurosurveillance - April 11, 2024 Category: Infectious Diseases Authors: Sarah K N ørgaard, Jens Nielsen, Anne Christine Nordholm, Lukas Richter, Alena Chalupka, Natalia Bustos Sierra, Toon Braeye, Maria Athanasiadou, Theodore Lytras, Gleb Denissov, Oskari Luomala, Anne Fouillet, Isabelle Pontais, Matthias an der Heiden, Bene Source Type: research
Emergence of OXA-48-like producing Citrobacter species, Germany, 2011 to 2022
ConclusionIn CF in Germany, OXA-48 is the predominant carbapenemase. Dissemination is likely due to distinct highly transmissible plasmids harbouringblaOXA‑48 orblaOXA-48-like and the spread of the high-risk clonal lineages ST19 and ST22. (Source: Eurosurveillance)
Source: Eurosurveillance - April 11, 2024 Category: Infectious Diseases Authors: Julian Sommer, Hannah Reiter, Janko Sattler, Elisabetta Cacace, Jessica Eisfeld, S ören Gatermann, Axel Hamprecht and Stephan Göttig Source Type: research
